Clinical TrialID 6877
Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis
NCT01321164
Plaque Psoriasis
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6877
- Evidence Id
- 6877
- Core Evidence Id
- 6877
- Source Clinical Trial Id
- 6869
- Herb2 Clinical Trial Id
- HBCT006869
- Nct Id
- NCT01321164
- Title
- Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Plaque Psoriasis
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DEVICE: Full Body UV Therapy System UV 7002 plus fumaric acid esters|DRUG: Fumaric acid esters
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 30
- Outcome Measure
- Mean reduction in Psoriasis Area and Severity Index (PASI), Baseline and 6 weeks
- Sponsor Collaborator
- Medical University of Vienna
- Funded By
- OTHER
- Location
- Medical University of Vienna; Department of Dermatology, Vienna, 1090, Austria
- Other Id
- FPUVB 005
- Start Date
- 2011-04
- Primary Completion Date
- 2013-12
- Completion Date
- 2014-04
- First Posted
- 2011-03-23
- Results First Posted
- Last Update Posted
- 2014-05-12
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01321164
- Title Cn
- Title En
- Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis
- Bilingual Status
- semi_complete